Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818490 · ClinicalTrials.gov registry record · NA
Aromatherapy for Anxiety Among Children With Autism Spectrum Disorder
A NA study, sponsored by Nutraceuticals Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03818490: Completed NA study, sponsored by Nutraceuticals Research Institute.
NCT03818490 is a NA study that has completed, run by Nutraceuticals Research Institute. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03818490, a NA study, has completed, sponsored by Nutraceuticals Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study evaluated the use of bergamot aromatherapy in the treatment of anxiety in a medical office setting among children who are diagnosed with an autism spectrum disorder. H
Primary Outcome
Self reported anxiety survey measuring state anxiety in children through 20 questions with a score ranging from 0-60 with higher scores representing higher anxiety.
Interventions
- OTHER Bergamot Aromatherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-06-24 |
| Est. Completion | 2018-03-30 |
| Phase | NA |
What the finished NCT03818490 record still lists
NCT03818490 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Bergamot Aromatherapy is the first listed.
NCT03818490 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03818490 about?
NCT03818490 is a clinical study titled "Aromatherapy for Anxiety Among Children With Autism Spectrum Disorder". This study evaluated the use of bergamot aromatherapy in the treatment of anxiety in a medical office setting among children who are diagnosed with an autism spectrum disorder. H
What is the current status of trial NCT03818490?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2016-06-24. Estimated completion is 2018-03-30.
What interventions are being tested in trial NCT03818490?
The interventions under investigation include: Bergamot Aromatherapy (OTHER).
Who is sponsoring clinical trial NCT03818490?
This trial is sponsored by Nutraceuticals Research Institute, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03818490's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI